"Nipocalimab Breakthrough Therapy Designation"
Digital Health News

Johnson & Johnson’s nipocalimab granted U.S. FDA Breakthrough Therapy Designation for the treatment of individuals at high risk for severe hemolytic disease of the fetus and newborn (HDFN)

Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) for nipocalimab for the treatment of alloimmunizeda pregnant individuals at high risk of severe hemolytic disease of the fetus and newborn (HDFN). Nipocalimab is currently the only therapy reported to be in clinical development for the treatment […]

Drugs & Meds

Nutrizoe launches Innovative dissolvable oral strips for pregnancy, periods, and nausea

Introducing a paradigm shift in drug delivery worldwide, dissolvable oral thin films (OTTFs) are a fast-emerging dosage alternative set to revolutionize the over-the-counter industry. Bringing the efficacy of these quick and effective solutions to the domain of women’s wellness in India, India’s first women-focused nourishment brand Nutrizoe, has launched three different sets of Oral Strips: Nail […]

Pandemic Pulse

A tête-à-tête with Dr. Kaberi Banerjee an IVF Specialist on rising pregnancy concern’s during the sweeping Covid-19 wave

As the second big wave of Covid-19 continues in India, women across the country have growing concerns and questions regarding various aspects of pregnancy. Dr. Kaberi Banerjee, Director of Advance Fertility and Gynaecology Centre sheds light on some of the most common worries that expecting mothers have. Excerpts from the interview below. What would you […]